Concepts (57)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 5 | 2018 | 68 | 0.940 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2020 | 38 | 0.510 |
Why?
|
| Gamma Rays | 1 | 2015 | 17 | 0.480 |
Why?
|
| Skin | 2 | 2012 | 115 | 0.470 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 38 | 0.470 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 104 | 0.430 |
Why?
|
| Head and Neck Neoplasms | 1 | 2015 | 151 | 0.420 |
Why?
|
| Phantoms, Imaging | 4 | 2020 | 39 | 0.380 |
Why?
|
| Scattering, Radiation | 3 | 2020 | 37 | 0.360 |
Why?
|
| Brachytherapy | 3 | 2017 | 56 | 0.340 |
Why?
|
| Radiosurgery | 2 | 2020 | 38 | 0.310 |
Why?
|
| Lung Neoplasms | 3 | 2020 | 552 | 0.250 |
Why?
|
| Monte Carlo Method | 3 | 2018 | 53 | 0.220 |
Why?
|
| Radiotherapy Dosage | 4 | 2017 | 117 | 0.200 |
Why?
|
| Radiometry | 4 | 2017 | 41 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2013 | 35 | 0.200 |
Why?
|
| Molecular Imaging | 1 | 2020 | 4 | 0.180 |
Why?
|
| Algorithms | 3 | 2018 | 380 | 0.160 |
Why?
|
| Photons | 1 | 2018 | 4 | 0.150 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2018 | 9 | 0.150 |
Why?
|
| Intraoperative Care | 1 | 2017 | 43 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 772 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 410 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 520 | 0.110 |
Why?
|
| Body Water | 1 | 2012 | 3 | 0.100 |
Why?
|
| Mice, Hairless | 1 | 2012 | 3 | 0.100 |
Why?
|
| Thermal Conductivity | 1 | 2012 | 3 | 0.100 |
Why?
|
| Tomography | 1 | 2012 | 13 | 0.100 |
Why?
|
| Thermography | 1 | 2012 | 14 | 0.100 |
Why?
|
| Radiation Injuries | 1 | 2012 | 32 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 176 | 0.100 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2011 | 3 | 0.090 |
Why?
|
| Logistic Models | 1 | 2012 | 398 | 0.090 |
Why?
|
| Mice | 2 | 2012 | 1467 | 0.090 |
Why?
|
| Tomography, Spiral Computed | 1 | 2011 | 28 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2011 | 205 | 0.080 |
Why?
|
| Humans | 8 | 2020 | 28554 | 0.080 |
Why?
|
| Animals | 2 | 2012 | 3814 | 0.070 |
Why?
|
| Female | 4 | 2013 | 15821 | 0.050 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2018 | 5 | 0.040 |
Why?
|
| Male | 1 | 2015 | 15401 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 30 | 0.040 |
Why?
|
| Water | 1 | 2017 | 32 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2017 | 52 | 0.040 |
Why?
|
| Organs at Risk | 1 | 2013 | 9 | 0.030 |
Why?
|
| Rectum | 1 | 2013 | 45 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2013 | 22 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 52 | 0.030 |
Why?
|
| X-Ray Film | 1 | 2011 | 3 | 0.020 |
Why?
|
| Artifacts | 1 | 2011 | 33 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 438 | 0.020 |
Why?
|
| Software | 1 | 2011 | 68 | 0.020 |
Why?
|
| Equipment Design | 1 | 2011 | 155 | 0.020 |
Why?
|
| Metals | 1 | 2011 | 152 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 235 | 0.020 |
Why?
|
| Biomarkers | 1 | 2012 | 601 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 3622 | 0.010 |
Why?
|